l-carnitine in management of valproic acid induced hyperammonemia Mechanism (VPA)-induced hyperammonemia. (1) VPA is Reversible weakness and encephalopathy while

Reversible weakness and encephalopathy while on long term valproate treatment due to carnitine deficiency BMJ Case Reports Valproic AcidInduced Hyperammonemia and Thrombocytopenia in an Elderly Woman Semantic Scholar Science review: Carnitine in the treatment of valproic acid induced toxicity what is the evidence? PMC Science review: Carnitine in the treatment of valproic acid induced toxicity what is the evidence? Critical Care Springer Nature Link

SKU: 77131554335 · From www.marsberger-treibhaus.de